搜索筛选:
搜索耗时0.0917秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
类      型:
[会议论文] 作者:JianlinXu,BoJin,TianqinChu,YuqingLou,XueyanZhang,HuiminWang,BaohuiHan, 来源:2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份:2016
目的 ThediscoveryofEGFRasadrivinggeneinNSCLCheraldedthebeginningoftheeraofprecisionmedicineforNSCLC.ThisarticlereportedtreatmentpatternsandoutcomesofpatientswhoreceivedEGF...
[会议论文] 作者:JianlinXu,xueyanZhang,BoJin,tianqinChu,HuimingWang,YuqingLou,baohuiHan, 来源:2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份:2016
目的 Wesummarizetheclinicaldataofthispopulationandtheirsensitivitytofirst-,orsecond-lineEGFRTKItherapy.方法 AdvancedNSCLCpatientswith19delor21L858RwhousedtoreceiveEGFRTKIasf...
[会议论文] 作者:JianlinXu,HaitangYang,BoJin,TianqinChu,XueyanZhang,YuqingLou,HuiminWang,BaohuiHan, 来源:2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份:2016
目的 TheefficacyofEGFRtyrosinekinaseinhibitors(TKIs)variesamongdifferentEGFRmutations.Here,wedirectlycomparedtheefficacyoffirst-lineTKIstochemotherapyfornon-smallcelllungcance...
[会议论文] 作者:BaohuiHan,BoJin,TianqinChu,YanjieNiu,HuaZhong,YuDong,AiqingGu,HuiminWang,XueyanZhang,PingGu,YuqingLou, 来源:2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份:2016
目的 To explore the optimal treatment strategy for patients who harbored a sensitive EGFR mutation.We did a head-to-headstudy to compare chemotherapy and gefitinib in combination with either agent alone...
相关搜索: